Anti-Bcl-7a

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
ELK-ES7053.50	50 µl		-	-	10 - 14 business days*		173.00€
ELK-ES7053.100	100 µl		-	-	10 - 14 business days*		290.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt... more

Close menu

Product information "Anti-Bcl-7a"

This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008], Recommended dilutions: Western Blot: 1/500 - 1/2000. ELISA: 1/5000. Not yet tested in other applications.. Cellular localization:

Keywords:	Anti-BCL7A, Anti-B-cell CLL/lymphoma 7 protein family member A, Bcl-7a rabbit pAb
Supplier:	ELK Biotechnology
Supplier-Nr:	ES7053

Properties

Application:	WB, ELISA
Antibody Type:	Polyclonal
Conjugate:	No
Host:	Rabbit
Species reactivity:	human, mouse
Immunogen:	The antiserum was produced against synthesized peptide derived from human BCL7A. AA range:21-70
MW:	22 kD
Format:	Antiserum